SBI Securities’s Purple Biotech PPBT Stock Holding History

SBI Securities’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6	Buy	4 +1	+33%	+$2	﹤0.01%	4040
2026 Q2	$5	Sell	3 -28	-90%	-$94	﹤0.01%	3987
2026 Q1	$125	Sell	31 -1	-3%	-$5	﹤0.01%	3359
2025 Q4	$210	Buy	32 +30	+1,500%	+$218	﹤0.01%	3200
2025 Q3	$11	Hold	2	–	–	﹤0.01%	4025
2025 Q2	$47	Hold	2	–	–	﹤0.01%	3736
2025 Q1	$53	Sell	2 -17	-89%	-$543	﹤0.01%	3629
2024 Q4	$891	Buy	+19	New	+$731	﹤0.01%	2662

Other funds holding PPBT

SmartHarvest Portfolios Poulsbo, Washington $258M AUM 39.79% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

SBI Securities's PPBT Position: Q3 2026 in Review

SBI Securities increased its Purple Biotech (PPBT) stake by 33% in Q3 2026, buying an estimated $2 and bringing the position to 4 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #4040.

SBI Securities first reported a position in PPBT in Q4 2024 and has held it in 8 quarters since. The position peaked at $891 in Q4 2024. 3 funds tracked by Wall St. Rank hold PPBT as of Q3 2026.

SBI Securities held 4 shares of Purple Biotech worth $6 as of Q3 2026.
SBI Securities bought 1 Purple Biotech share in Q3 2026, an estimated $2.
Purple Biotech made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #4040 holding.
SBI Securities first reported a position in Purple Biotech in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Purple Biotech position peaked at $891 in Q4 2024.
3 funds tracked by Wall St. Rank held Purple Biotech as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.